tiprankstipranks
Advertisement
Advertisement

Starcoin Group Shares to Remain Suspended After HKEX Cites Insufficient Operations and Asset Support

Story Highlights
  • Starcoin Group’s listing is at risk as HKEX upholds a suspension over insufficient operations and assets.
  • Limited revenue, early-stage projects and heavy reliance on intangible assets heighten viability concerns for investors.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Starcoin Group Shares to Remain Suspended After HKEX Cites Insufficient Operations and Asset Support

Meet Samuel – Your Personal Investing Prophet

Innovative Pharmaceutical Biotech ( (HK:0399) ) has issued an update.

Starcoin Group Limited has been notified by the Hong Kong Stock Exchange’s Listing Committee that it failed to maintain a sufficient level of operations and assets of adequate value to justify its continued listing, leading to a decision to uphold the suspension of trading in its shares. The committee cited the company’s limited operating scale, lack of revenue from its research and development activities, early-stage status of newer ventures such as health supplements and blockchain technology, and profit forecasts lacking strong evidence, alongside concerns over its heavy reliance on intangible assets, unresolved maturity extensions for significant convertible bonds and ongoing going-concern uncertainties, all of which raise significant questions about the viability and sustainability of the business for investors and other stakeholders.

The most recent analyst rating on (HK:0399) stock is a Sell with a HK$0.08 price target. To see the full list of analyst forecasts on Innovative Pharmaceutical Biotech stock, see the HK:0399 Stock Forecast page.

More about Innovative Pharmaceutical Biotech

Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is a Hong Kong-listed company incorporated in the Cayman Islands and continued in Bermuda, with operations that have included trading activities, research and development projects, health supplements and blockchain-related initiatives. Despite holding total assets of about HK$1.1 billion as of 30 September 2025, much of this value is tied up in intangible assets linked to projects with uncertain commercial prospects, and the group is burdened by net current liabilities largely stemming from convertible bonds.

Average Trading Volume: 18,495,063

Technical Sentiment Signal: Sell

Current Market Cap: HK$182.1M

Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1